Journal of Comparative Effectiveness Research

Article	Citations
Cost–effectiveness of pembrolizumab for second-line treatment of esophageal squamous cell carcinoma patients with a combined positive score of 10 or more	146
Acute effects of resistance exercise with blood flow restriction on cardiovascular response: a meta-analysis	42
Effect of home-based exercise programs with e-devices on falls among community-dwelling older adults: a meta-analysis	41
Engaging veterans in the research process: a practical guide	36
An observational cohort study of pelvic floor photobiomodulation for treatment of chronic pelvic pain	28
Long-term effectiveness and safety of ravulizumab in paroxysmal nocturnal hemoglobinuria: a plain language summary	28
Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost–effectiveness analysis	25
Journal of Comparative Effectiveness Research : 2022 year in review	22
Economic burden of sickle cell disease in the United States: a retrospective analysis of a commercial insurance database	22
Smart connected insulin dose monitoring technologies versus standard of care: a Canadian cost–effectiveness analysis	22
MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy	21
Discharges against medical advice and 30-day healthcare costs: an analysis of commercially insured adults	20
Corrigendum	20
Postoperative outcomes and anesthesia type in total knee arthroplasty in patients with obstructive sleep apnea	20
Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study	19
Cost–effectiveness analysis of a resource-intensive approach versus minimally invasive strategy for high-risk transcatheter aortic valve replacement patients	19
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 20	19
Impact of clinical research coordinators on research output in orthopedic surgery	19
Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1: a systematic literature review and network meta-analysis	16
Effectiveness and safety of asfotase alfa for people with hypophosphatasia: a plain language summary of three studies	16
Impact of surgical complications on hospital costs and revenues: retrospective database study of Medicare claims	15
Letter in reply	15
Clinical assessment of the potential use of a novel single-dose prefilled injection device for the administration of Acthar Gel in children: a narrative review	14
Ravulizumab in adults and children with atypical hemolytic uremic syndrome: a plain language summary of three studies	14
Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity	14

Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience	13
Healthcare utilization and costs following molecular diagnostic testing among patients with vaginitis	13
The cost–effectiveness of pegcetacoplan in complement treatment-naïve adults with paroxysmal nocturnal hemoglobinuria in the USA	13
Clinical manifestations and healthcare utilization before diagnosis of transthyretin amyloidosis	12
Cost of disease progression among US patients with human epidermal growth factor receptor 2-positive metastatic breast cancer	12
R WE ready for reimbursement? A round up of developments in real-world evidence relating to HTA: part 3	12
EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?	12
Cost–effectiveness analysis of prolonged-release fampridine to treat walking disability of multiple sclerosis in China	12
Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases	12
Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients	11
A real-world analysis of antidepressant medications in US veterans aged 60 years and older: a comparative analysis	11
Real-world ePRO use and clinical outcomes using electronic patient-reported symptom monitoring for patients with advanced non-small-cell lung cancer receiving first-line pembrolizumab	11
Cost–effectiveness of lung cancer screening with volume computed tomography in Portugal	11
Increasing transparency in indirect treatment comparisons: is selecting effect modifiers the missing part of the puzzle? A review of methodological approaches and critical considerations	10
Healthcare costs and resource utilization of patients with chronic post-traumatic stress disorder: a retrospective US claims analysis of commercially insured patients	10
Network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema	10
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada	10
Corrigendum	10
Real-world weight changes in people with HIV-1 at risk of weight gain (female, Black or Hispanic) switching from integrase strand transfer inhibitors	9
How the use of standardized protocols may paradoxically worsen disparities for safety-net hospitals	9
The triple win – implementation science benefits patients, healthcare systems and industry alike	9
Evaluation of patient/caregiver and healthcare provider knowledge, attitudes and behavior for safety and use of pexidartinib	9
Review and estimation of disutility for joint health states of severe and nonsevere hypoglycemic events in diabetes	9
Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer	9
Cost–utility analysis of single nucleotide polymorphism panel-based machine learning algorithm to predict risk of opioid use disorder	9
Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer	9
To replicate or not to replicate? Insights and interpretations from a randomized trial duplication initiative	9
Evidence-based public policy making for medicines across countries: findings and implications for the future	9
Comparison of intravenous versus topical tranexamic acid in primary total hip arthroplasty: a systematic review and meta-analysis of ten randomized trials	9
Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studies	9
Impact analysis of expanding narrow-spectrum antibiotic use for children with ear, sinus and throat infections	8
Comparison of Enterprise stent 2 with 1 in assisting coiling of ruptured aneurysms: a real-world study	8
Diversity in clinical trial inclusion for peripheral artery disease lower extremity endovascular interventions: a systematic review protocol	8
Characterization of medical device randomized controlled trials with adaptive designs	8
Healthcare resource utilization and costs in pediatric pulmonary arterial hypertension in a third-level hospital in Mexico	8
Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol	8
Effectiveness of tisagenlecleucel versus real-world standard of care in relapsed/refractory follicular lymphoma	8
Impact of COVID-19 on chronic pain structures: data from French national survey	8
Dependent censoring bias assessment using inverse probability of censoring weights: Type 2 diabetes mellitus risk in patients initiating bisoprolol versus other antihypertensives in a Clinical Practic	8
Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema	8
Single-arm oncology trials and the nature of external controls arms	7
The effects of Pilates on pain, functionality, quality of life, flexibility and endurance in lumbar disc herniation	7
COVID-19 clinical trials: who is likely to participate and why?	7
Uricemia in the acute phase of myocardial infarction and its relation to long-term mortality risk	7
Does off-hours endoscopic hemostasis affect outcomes of nonvariceal upper gastrointestinal bleeding?	7
Rivaroxaban versus low-molecular-weight heparins for short- and long-term prognosis in patients with deep vein thrombosis after spontaneous intracranial hemorrhage	7
Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care	7
An impact evaluation of an education bundle for patients at risk of developing venous thromboembolism	7
Comparative effectiveness research in COVID-19 using real-world data: methodological considerations	7
Access in all areas? A round up of developments in market access and health technology assessment: part 1	7

Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in colorectal cancer: a meta-analysis	7
Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome	7
Tr14 gel for the treatment of acute ankle sprains: a plain language summary of the TRAUMED trial	7
Cost–effectiveness of empagliflozin versus weekly semaglutide as add-on therapy for Type 2 diabetes	7
The impact of lower limb chronic venous disease on quality of life: patient and physician perspectives	6
Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case–control design	6
Use of transportability methods for real-world evidence generation: a review of current applications	6
A systematic review of discounting in national health economic evaluation guidelines: healthcare value implications	6
Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers	6
Quality in qualitative evidence: new best practice principles from NICE’s real-world evidence framework	6
An economic evaluation of teledermatology care delivery for chronic skin diseases	6
Cost–effectiveness of ensartinib for patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer in China	6
Treatment goals for rheumatoid arthritis: patient engagement and goal collection	6
Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary	6
Teclistamab versus real-world physician’s choice of therapy in triple-class exposed relapsed/refractory multiple myeloma	6
Burden of illness for patients with primary biliary cholangitis: an observational study of clinical characteristics and healthcare resource utilization	6
Expanding the learning health system model to be health literate	6
Assessing the change in disease severity based on depressive symptoms in real-world psoriasis patients	6
A value-based budget impact model for dronedarone compared with other rhythm control strategies	6
Application of quantitative bias analysis for unmeasured confounding in cost–effectiveness modelling	6
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10	6
Navigating adalimumab biosimilars: an expert opinion	6
Corrigendum	6
An evaluation of stakeholder engagement in comparative effectiveness research: lessons learned from SWOG S1415CD	6
A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib	5
Vaginal laser therapy for gynecologic conditions: re-examining the controversy and where do we go from here	5
Mapping methods gaps between EU joint clinical assessments and local health technology assessment decision-making: an environmental scan of guidance in select EU markets and harmonization challenges	5
QDOT MICRO™ versus THERMOCOOL ® SMARTTOUCH™ and THERMOCOOL SMARTTOUCH ® Surround Flow in radiofrequency ablation of paroxysmal atr	5
Adverse event costs of systemic therapies for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy and biologics in the US	5
Robotic-assisted total hip arthroplasty: an economic analysis	5
In-hospital mortality in amyloid light chain amyloidosis: analysis of the Premier Healthcare Database	5
Navigating the unknown: how to best ‘reflect’ standard of care in indications without a dedicated treatment pathway in health technology assessment submissions	5
Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data	5
Expert perspectives on the use of safinamide for Parkinson’s disease in Portugal: insights from a Portuguese Delphi Consensus	5
COVID-19 complications in males and females: recent developments	5
Economic impact of reduced postoperative visits after inflatable penile prosthesis implantation	5
Letter in Reply: indirect comparison of quality-of-life scores between patients with advanced breast cancer receiving palbociclib and abemaciclib in combination with fulvestrant	5
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15	5
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 4	4
Impact analysis of expanded access to ketamine for treatment-resistant depression	4
Safety and effectiveness of intranasal esketamine for treatment-resistant depression: a real-world retrospective study	4
Semaglutide treatment for obesity in teenagers: a plain language summary of the STEP TEENS research study	4
A review of stakeholder recommendations for defining fit-for-purpose real-world evidence algorithms	4
Why, whether and how to use high-flow nasal therapy in acute exacerbations of chronic obstructive pulmonary disease	4
Are eSports more than just sitting? A study comparing energy expenditure	4
Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USA	4
Efficacy of CARVYKTI in CARTITUDE-4 versus other conventional treatment regimens for lenalidomide-refractory multiple myeloma using inverse probability of treatment weighting	4
Evaluation of inpatient and emergency department healthcare resource utilization and costs pre- and post-nusinersen for the treatment of spinal muscular atrophy using United States claims	4
Resource utilization and economic outcomes following repetitive transcranial magnetic stimulation for treatment-resistant depression: a retrospective observational analysis	4
How pharma can amplify product value with implementation science	4
Clinical and economic implications of focal dissection treatment following percutaneous transluminal angioplasty of the superficial femoral artery: an exploratory analysis based on the TOBA II Study	4
Impact of comparative effectiveness research on Medicare coverage of direct oral anticoagulants	4
Steroid switching in dystrophinopathy treatment: a US chart review of patient characteristics and clinical outcomes	4
Structural hemodynamic valve deterioration durability of RESILIA-tissue versus contemporary aortic bioprostheses	4
Plain language summary: Clinical study of BI 1015550 as a potential treatment for idiopathic pulmonary fibrosis	4
Sex-based differences in the outcomes of patients with lung carcinoids	4
Economic burden of lives lost due to COVID-19 in California State	4
Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes	4
Visualizing the target estimand in comparative effectiveness studies with multiple treatments	4
Economic burden of early-stage non-small-cell lung cancer: an assessment of healthcare resource utilization and medical costs	4
An international observational study assessing conservative management in hemorrhoidal disease: results of CHORALIS (aCute HemORrhoidal disease evALuation International Study)	4
Budesonide/formoterol versus salmeterol/fluticasone for asthma in children: an effectiveness and safety analysis	4
Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data inROS1+ NSCLC	4
Respiratory and nonrespiratory COVID-19 complications in patients with obesity: recent developments	4
R WE ready for reimbursement? A round up of developments in RWE relating to health technology assessment: part 2	4
Cost–effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma	4
Budget impact analyses of hemoglobin A1c and lipid panel point-of-care testing with Afinion™ 2 in Canada and Italy	4
Potential policy reforms to strengthen the accelerated approval pathway	4
Val (EU) xit: do we need an international ISPOR value flower?	4
Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis utilizing patient-level and aggregate data	4
The need to consider market access for pharmaceutical investment decisions: a primer	4
Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making	3
Cost impact of Bruton’s tyrosine kinase inhibitor selection in Medicare patients with chronic lymphocytic leukemia	3
A clinical decision support tool for metabolic dysfunction-associated steatohepatitis in real-world clinical settings: a mixed-method implementation research study protocol	3
Cost–effectiveness analysis of Avance ® allograft for the treatment of peripheral nerve injuries in the USA	3
Cost–effectiveness of concurrent radiation with cetuximab or chemotherapy in older patients with oropharyngeal cancer	3
Evaluating the robustness of an AI pathfinder application on eligibility criteria in multiple myeloma trials using real-world data and historical trials	3
A network meta-analysis of immunotherapy-based treatments for advanced nonsquamous non-small cell lung cancer	3
The burden of Alagille syndrome: uncovering the potential of emerging therapeutics – a comprehensive systematic literature review	3
Novel and existing flexible survival methods for network meta-analyses	3

Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis	3
Systematic literature review of evidence in amyloid light-chain amyloidosis	3
Corrigendum	3
Rational use of inhaled corticosteroids for the treatment of COPD: a plain language summary	3
Factors impacting chronic disease medication adherence in the UAE: a prospective cohort study, 2021–2022	3
PEG hydrogel sealant versus fibrin glue in posterior fossa surgery: an economic comparison across five European countries	3
The effects of exercises with a Pilates ball on balance, reaction time and dual-task performance of kindergarten children	3
Distinguishing cardiac catheter ablation energy modalities by applying natural language processing to electronic health records	3
Access in all areas? a round up of developments in market access and health technology assessment: part 4	3
Outcomes of patients with nonmetastatic gastric adenocarcinoma according to perioperative treatment strategy: a real-world, population-based study	3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 19	3
Screening for diminished ovarian reserve in Portugal: a cost-saving answer to shorten the fertility journey	3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17	3
A real world cost-minimization analysis comparing the use of different endoscopic staplers in video-assisted thoracic surgery lobectomy procedures	3
Implementation of electronic patient-reported outcomes for symptom monitoring during cancer treatment: the importance of getting it right	3
Matching-adjusted indirect comparison via a polynomial-based non-linear optimization method	3
Assessing the performance of physician's prescribing preference as an instrumental variable in comparative effectiveness research with moderate and small sample sizes: a simulation study	3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18	3
Cost–effectiveness of cladribine tablets and dimethyl fumarate in the treatment of relapsing remitting multiple sclerosis in Spain	3
Comparing the performance of two-stage residual inclusion methods when using physician's prescribing preference as an instrumental variable: unmeasured confounding and noncollapsibility	3
Meta-analysis of visual pretreatment for the prevention of emergence delirium in children undergoing ophthalmic surgery	3
Six-minute walk test as clinical end point in cardiomyopathy clinical trials, including ATTR-CM: a systematic literature review	3
Letter in reply: network meta-analysis for indirect comparison of lanadelumab and for the treatment of hereditary angioedema	3
Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study	3
Access in all areas? A roundup of developments in market access and health technology assessment: part 6	3
Network meta-analysis of multiple doses of vonoprazan for the treatment of erosive esophagitis	3
Clinical outcomes of retrievable inferior vena cava filters for venous thromboembolic diseases	3
Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary	3
Economic burden of complicated ureteral stent removal in patients with kidney stone disease in the USA	3
Use of interrupted time-series analyses in evaluating health economic outcomes following implementation of multilayer water-tight wound closure in a primary total joint arthroplasty population	3
The views of teenagers with obesity, their caregivers, and doctors: a plain language summary of the ACTION Teens global survey	3
Real-world studies of crizotinib in patients with ROS1-positive non-small-cell lung cancer: experience from China	3
Promoting community stakeholder engagement in research on treatment for pregnant women with opioid use disorder	3
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis	3
Missing data methods for intensive care unit SOFA scores in electronic health records studies: results from a Monte Carlo simulation	3
Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study	3
Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema	3
Cost–effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain	3
The cost–effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark	3
Patterns and association of vaccination among adults with a history of cancer in the USA: a population-based study	3
A US national update of health condition prevalence among privately-insured autistic adults	3
Comparing the outcomes and costs of cardiac monitoring with implantable loop recorders and mobile cardiac outpatient telemetry following stroke using real-world evidence	3
A process to validate prognostic factors for unanchored matching-adjusted indirect comparison of single-arm trials in oncology: a proof-of-concept study	3
Letter to the Editor: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus	3
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis	3
A protocol for three observational cohort studies evaluating adverse outcomes, excess costs and repeat procedures after surgery for breast cancer in the USA	3
Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment c	3
Prognostic and predictive value of microsatellite instability status among patients with colorectal cancer	3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to HTA: part 5	2
Healthcare utilization among children with early autism diagnoses, children with other developmental delays and a comparison group	2
Acceptability and consumers' willingness to pay for comprehensive medication management services in Brazil	2
The use of nonrandomized evidence to estimate treatment effects in health technology assessment	2
Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy	2
Journal of Comparative Effectiveness Research welcoming the submission of study design protocols to foster transparency and trust in real-world evidence	2
Advantages of robotic arm-assisted total hip arthroplasty: a 90-day episode-of-care clinical utility and cost analysis	2
Phosphodiesterase type 5 inhibitors as treatment for erectile dysfunction: a webinar-based poll unveiling perceptions of healthcare professionals	2
Trends in adoption of knotless tissue control devices in robotic surgery	2
A novel injection device to administer repository corticotropin injection for inflammatory disease treatment: findings from a market research study	2
Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas that can't be removed by surgery, and impact on how the condition affects caregivers: a plain language summary	2
The cost–effectiveness, of pegcetacoplan compared with ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria, in a UK setting	2
Breast-conserving surgery versus mastectomy for older women with triple-negative breast cancer: population-based study	2
Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus	2
Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver	2
Digital variance angiography in patients undergoing lower limb arterial recanalization: cost–effectiveness analysis within the English healthcare setting	2
Design and methods of a tailored approach for diabetes prevention in women with previous gestational diabetes	2
The economic impact of stent retriever selection for acute ischemic stroke: a cost analysis of MASTRO I from the healthcare system perspective of the United States, Canada and eight European countries	2
Perceptions of indirect treatment comparisons as an evidence base in oncology decision-making: results of an international survey of health technology assessment and payer decision-makers	2
Visualizing the randomized sham-controlled trial in orthopedic research: proposed steps to conducting a total knee arthroplasty randomized controlled trial	2
Healthcare resource utilization among nursing home residents with Parkinson's disease psychosis: an analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics	2
Corrigendum	2
Elranatamab versus physician’s choice of treatment in patients with triple-class exposed/refractory multiple myeloma: an updated matching-adjusted indirect comparison	2
Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema	2
Corrigendum	2
A real-world, population-based study for the outcomes of patients with metastatic colorectal cancer to the liver with distant lymph node metastases treated with metastasectomy	2
Evaluation of reporting in time-driven activity-based costing studies on cardiovascular diseases: a scoping review	2
Why is target trial emulation not being used in health technology assessment real-world data submissions?	2
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy	2
Evaluating patients' satisfaction and preferences with a secondary prevention cardiovascular polypill: the Aurora Study	2
Bridging the gap between oncology clinical trials and real-world data: evidence on replicability of efficacy results using German claims data	2
Effects of 12-week Pilates training program on cardiac autonomic modulation: a randomized controlled clinical trial	2
Regional differences in the utilization and outcomes of cerebral embolic protection during transcatheter aortic valve replacement: an analysis of the National Inpatient Sample from 2017 through 2019	2
Access in all areas? A round up of developments in market access and HTA: part 5	2
Institute for Clinical and Economic Review – Peterson Health Technology Institute value assessment framework for digital health technologies	2
Flexibility in assessment of rare disease technologies via NICE's single technology appraisal route: a thematic analysis	2
Impact analysis of expanding anti-TNF therapy for Crohn’s disease	2
Real-world evidence: a practical toolbox for collecting health state utilities	2
Improved estimation of overall survival and progression-free survival for state transition modeling	2